Julita Szulimowska

Julita Szulimowska

Auto-generated profile, based on publicly available information

Julita Szulimowska

Department of Pedodontics, Medical University of Bialystok, Bialystok, Poland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
Mateusz MaciejczykMateusz Maciejczyk
Mateusz Maciejczyk
Miłosz NesterowiczMiłosz Nesterowicz
Miłosz Nesterowicz
JSJulita Szulimowska
Julita Szulimowska
Anna ZalewskaAnna Zalewska
Anna Zalewska
Background: Aging is inextricably linked to oxidative stress, inflammation, and posttranslational protein modifications. However, no studies evaluate oxidation, glycation, and carbamylation of salivary biomolecules as biomarkers of aging. Saliva collection is non-invasive, painless, and inexpensive, which are advantages over other biofluids. Methods: The study enrolled 180 healthy subjects divided into six groups according to age: 6– 13, 14– 19, 20– 39, 40– 59, 60– 79, and 80– 100 years. The number of individuals was determined a priori based on our previous experiment (power of the test = 0.8; α = 0.05). Non-stimulated saliva and plasma were collected from participants, in which biomarkers of aging were determined by colorimetric, fluorometric, and ELISA methods. Results: The study have demonstrated that modifications of salivary proteins increase with age, as manifested by decreased total thiol levels and increased carbonyl groups, glycation (Nϵ-(carboxymethyl) lysine, advanced glycation end products (AGE)) and carbamylation (carbamyl-lysine) protein products in the saliva of old individuals. Oxidative modifications of lipids (4-hydroxynonenal) and nucleic acids (8-hydroxy-2’-deoxyguanosine (8-OHdG)) also increase with age. Salivary redox biomarkers correlate poorly with their plasma levels; however, salivary AGE and 8-OHdG generally reflect their blood concentrations. In the multivariate regression model, they are a predictor of aging and, in the receiver operating characteristic (ROC) analysis, significantly differentiate children and adolescents (under 15 years old) from the working-age population (15– 64 years) and the older people (65 years and older). Conclusion: Salivary AGE and 8-OHdG have the most excellent diagnostic utility in assessing the aging process. Saliva can be used to evaluate the aging of the body. Graphical Abstract:

21 May 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SCSandra Benito Cid
Sandra Benito Cid
NUNora Unceta
Nora Unceta
Mateusz MaciejczykMateusz Maciejczyk
Mateusz Maciejczyk
ASAlicia Sánchez-Ortega
Alicia Sánchez-Ortega
KTKatarzyna Taranta-Janusz
Katarzyna Taranta-Janusz
RBRamon Barrio
Ramon Barrio
Pediatric chronic kidney disease (CKD) is a clinical condition characterized by progressive renal function deterioration. CKD diagnosis is based on glomerular filtration rate, but its reliability is limited, especially at the early stages. New potential biomarkers (citrulline (CIT), symmetric dimethylarginine (SDMA), S-adenosylmethionine (SAM), n-butyrylcarnitine (nC4), cis-4-decenoylcarnitine, sphingosine-1-phosphate and bilirubin) in addition to creatinine (CNN) have been proposed for early diagnosis. To verify the clinical value of these biomarkers we performed a comprehensive targeted metabolomics study on a representative cohort of CKD and healthy pediatric patients. Sixty-seven children with CKD and forty-five healthy children have been enrolled in the study. Targeted metabolomics based on liquid chromatography-triple quadrupole mass spectrometry has been used for serum and plasma samples analysis. Univariate data analysis showed statistically significant differences (p < 0.05) in the concentration of CNN, CIT, SDMA, and nC4 among healthy and CKD pediatric patients. The predictive ability of the proposed biomarkers was also confirmed through specificity and sensitivity expressed in Receiver Operating Characteristic curves (AUC = 0.909). In the group of early CKD pediatric patients, AUC of 0.831 was obtained, improving the diagnostic reliability of CNN alone. Moreover, the models built on combined CIT, nC4, SDMA, and CNN allowed to distinguish CKD patients from healthy control regardless of blood matrix type (serum or plasma). Our data demonstrate potential biomarkers in the diagnosis of early CKD stages.

3 December 2013 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
Anna ZalewskaAnna Zalewska
Anna Zalewska
JSJulita Szulimowska
Julita Szulimowska
Napoleon WaszkiewiczNapoleon Waszkiewicz
Napoleon Waszkiewicz
DWDanuta Waszkiel
Danuta Waszkiel
KZKrzysztof Zwierz
Krzysztof Zwierz
MKMalgorzta Knas-Dawidziuk
Malgorzta Knas-Dawidziuk
The aim of the present study was to evaluate the possibility of making use of the specific activity of N-acetyl-β-hexosaminidase, its isoenzymes and β-glucuronidase--potential indicators of salivary gland damage--in the detection of early onset of salivary gland impairment in RA, which is also demonstrated by xerostomia. For this purpose RA xerostomic salivary patients (unstimulated salivary flow >0.1 mL/min) were compared with RA xerostomic hyposalivary patients (unstimulated salivary flow ≤0.1 mL/min), RA patients without xerostomia (unstimulated salivary flow >0.1 mL/min) and generally healthy controls (unstimulated salivary flow >0.1 mL/min, without xerostomia). Salivary N-acetyl-β-hexosaminidase, its isoenzymes A and B, and β-glucuronidase specific activity were determined according to the Marciniak et al. method. The protein content in the unstimulated saliva was determined by the bicinchoninic acid method. In xerostomic rheumatoid arthritis patients, the specific activity of salivary β-glucuronidase and isoenzyme A was significantly higher than in the healthy controls but the specific activity of salivary N-acetyl-β-hexosaminidase, its isoenzyme B and β-glucuronidase was significantly lower than in xerostomic hyposalivary rheumatoid arthritis patients. We suggest a simple, safe and cheap method for the determination of exoglycosidases as a useful tool for the diagnosis of early stages of salivary gland involvement in rheumatoid arthritis.

26 October 2023 in Medical Science Monitor
Verified
Journal Article
Open access
JSJulita Szulimowska
Julita Szulimowska
AZAnna Zalewska
Anna Zalewska
KTKatarzyna Taranta-Janusz
Katarzyna Taranta-Janusz
DTDaria Trocka
Daria Trocka
MŻMałgorzata Żendzian-Piotrowska
Małgorzata Żendzian-Piotrowska
Mateusz MaciejczykMateusz Maciejczyk
Mateusz Maciejczyk
Background: Ischemia-modified albumin (IMA) is a secreted biomarker for ischemic oxidative stress. This case-control study aimed to evaluate the association of ischemia-modified albumin (IMA) in saliva, serum, and urine with diagnosis of chronic kidney disease (CKD) in 24 children. Material/Methods: The study involved 24 children with CKD. CKD was defined according to the Kidney Disease Improving Global Outcomes (KDIGO) diagnostic criteria. The control group consisted of 24 healthy children who were matched for age and gender to the experimental group. The concentration of IMA was determined by the colorimetric method in non-stimulated whole saliva (NWS), stimulated whole saliva (SWS), serum, and urine of children with CKD. The Mann-Whitney U test was used for inter-group comparisons. Results: IMA levels were significantly higher in NWS (P=0.0082) and SWS (P=0.0014) of children with CKD than in the control group. The concentration of IMA in NWS was correlated with standard indicators of kidney function, including the estimated glomerular filtration rate (r=-0.798, P <= 0.0001), stage of CKD (r=0.814, P <= 0.0001), and serum creatinine (r=0.711, P <= 0.0001) and urea levels (r=0.738, P <= 0.0001). Conclusions: Salivary IMA concentration depends on renal function in children. Salivary IMA discriminates children with endstage kidney disease from children with mild and moderate CKD and healthy children with high sensitivity and specificity. Further research is required, including assessment of the diagnostic usefulness and validation of the biomarker in a clinical diagnostic study.

4 December 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NUNora Unceta
Nora Unceta
ASAlicia Sánchez-Ortega
Alicia Sánchez-Ortega
AGAlberto Gómez-Caballero
Alberto Gómez-Caballero
LDLucia Diez-Caballero
Lucia Diez-Caballero
SCSandra Benito Cid
Sandra Benito Cid
KTKatarzyna Taranta-Janusz
Katarzyna Taranta-Janusz
Chronic kidney disease (CKD) results in severe morbidity and mortality in children; thus early diagnosis is essential to minimize long-term effects. This research aimed to unveil potential saliva biomarkers for improving early CKD diagnosis, as a non-invasive alternative to blood. An untargeted metabolomics method based on LC-QTOF-MS was applied to unstimulated and acid-stimulated saliva samples from children and adolescents suffering from CKD and healthy subjects. Partial Least Squares Method-Discriminant Analysis (PLS-DA) revealed different metabolic profiles in unstimulated and acid-stimulated saliva samples. The features significantly altered were identified based on their MS and MS/MS spectra and the analytical standards. Prolylproline, leucyl-leucine and pyroglutamyl-leucine were found to be increased in unstimulated saliva of CKD patients, while creatine, n-butyrylcarnitine and palmitic acid were altered in stimulated saliva. Hierarchical cluster analysis showed better grouping with biomarkers altered in stimulated saliva samples. According to Receiver Operating Characteristic (ROC) curves generated using PLS-DA discriminant method, these biomarkers (AUC = 0.999) also provided better prediction accuracy than those in unstimulated samples (AUC = 0.874), demonstrating the relevance of the collection method in the metabolic profile of saliva. Hence, as long as the collection method is considered, the salivary metabolome was proven to be a tool of choice for pediatric CKD diagnosis.